Behçet's ileocolitis: successful treatment with tumor necrosis factor-alpha antibody (infliximab) therapy: report of a case.

MT, Kram; LD, May; S, Goodman; S, Molinas

doi:10.1007/s10350-004-6506-4

Public

Behçet's ileocolitis: successful treatment with tumor necrosis factor-alpha antibody (infliximab) therapy: report of a case.

Shared by NobleBlocks on Jan 1, 2003 • 12:00 AM UTC

Authors:

Kram MT

May LD

Goodman S

Abstract

Behçet's disease is a chronic inflammatory disease characterized by recurrent oral aphthae and systemic manifestations. Gastrointestinal involvement is rare. We report a case of ileocolitis secondary to Behçet's successfully treated with tumor necrosis factor-alpha antibody (infliximab) therapy. To ...

Discussions